Commentary: Considering Treating Postoperative Atrial Fibrillation With Direct Oral Anticoagulants

      The evolving reputation of dual oral anticoagulants in treating patients with postoperative atrial fibrillation depends on safety, effect on long-term outcome and cost-effectiveness of the medication.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hage A.
        • Dolan D.P.
        • Nasr V.G.
        • et al.
        Safety of direct anticoagulants compared to warfarin for atrial fibrillation after cardiac surgery: A systematic review and meta-analysis.
        Semin Thorac Cardiovasc Surg. 2022; 34: 947-957
        • Di Lullo L.
        • Tripepi G.
        • Ronco C.
        • et al.
        Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor.
        Int J Cardiol. 2019; 278: 243-249
        • Rattazzi M.
        • Faggin E.
        • Beracco E.
        • et al.
        Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- mice.
        Cardiovasc Ther. 2018; 36: e12438
        • Eikelboom J.W.
        • Connolly S.J.
        • Brueckmann M.
        • et al.
        Dabigatran versus warfarin in patients with mechanical heart valves.
        N Engl J Med. 2013; 369: 1206-1214

      Linked Article

      • Safety of Direct Oral Anticoagulants Compared to Warfarin for Atrial Fibrillation after Cardiac Surgery: A Systematic Review and Meta-Analysis
        Seminars in Thoracic and Cardiovascular SurgeryVol. 34Issue 3
        • Preview
          The evidence for use of direct oral anticoagulants (DOACs) in the management of post-operative cardiac surgery atrial fibrillation is limited and mostly founded on clinical trials that excluded this patient population. We performed a systematic review and meta-analysis of clinical trials and observational studies to evaluate the hypothesis that DOACs are safe compared to warfarin for the anticoagulation of patients with post-operative cardiac surgery atrial fibrillation. We searched PubMed, EMBASE, Web of Science,, and the Cochrane Library for clinical trials and observational studies comparing DOAC with warfarin in patients ≥18 years old who had post-cardiac surgery atrial fibrillation.
        • Full-Text
        • PDF